Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|July 29, 2010
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosisA Dufresne, F Bertucci, N Penel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2015
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trialB Bui-Nguyen, J E Butrynski, N Penel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeN Penel, A Italiano, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)D Garbay, A Le Cesne, N Penel, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trialM Gross-Goupil, A Fourcade, E Blot, et al.
British Journal of Cancer|June 3, 2016
Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II studyF Mouriaux, V Servois, J J Parienti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trialB Bui-Nguyen, I Ray-Coquard, C Chevreau, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)T Valentin, A Le Cesne, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-upN Penel, A Le Cesne, B N Bui, et al.
BMC Cancer|October 17, 2015
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma GroupJ Khalifa, M Ouali, L Chaltiel, et al.
Pageof 11